Haag GM - Search Results

1

Surgical strategies in true adenocarcinoma of the esophagogastric junction (AEG II): thoracoabdominal or abdominal approach?

Blank S, Schmidt T, Heger P, Strowitzki MJ, Sisic L, Heger U, Nienhueser H, Haag GM, Bruckner T, Mihaljevic AL, Ott K, Büchler MW, Ulrich A. Blank S, et al. Among authors: haag gm. Gastric Cancer. 2018 Mar;21(2):303-314. doi: 10.1007/s10120-017-0746-1. Epub 2017 Jul 6. Gastric Cancer. 2018. PMID: 28685209

2

Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study.

Pant S, Schuler M, Iyer G, Witt O, Doi T, Qin S, Tabernero J, Reardon DA, Massard C, Minchom A, Lugowska I, Carranza O, Arnold D, Gutierrez M, Winter H, Stuyckens K, Crow L, Najmi S, Hammond C, Thomas S, Santiago-Walker A, Triantos S, Sweiti H, Loriot Y; RAGNAR Investigators. Pant S, et al. Lancet Oncol. 2023 Aug;24(8):925-935. doi: 10.1016/S1470-2045(23)00275-9. Lancet Oncol. 2023. PMID: 37541273 Clinical Trial.

3

Immediate tumor resection in patients with locally advanced gastroesophageal adenocarcinoma with nonresponse to chemotherapy after 4 weeks of treatment versus resection after completion of chemotherapy (OPTITREAT trial, DRKS00004668): study protocol for a randomized controlled pilot trial.

Blank S, Knebel P, Haag GM, Bruckner T, Klaiber U, Burian M, Schaible A, Sisic L, Schmidt T, Diener MK, Ott K. Blank S, et al. Among authors: haag gm. Pilot Feasibility Stud. 2016 Apr 4;2:18. doi: 10.1186/s40814-016-0059-x. eCollection 2016. Pilot Feasibility Stud. 2016. PMID: 27965838 Free PMC article.

4

Perioperative Chemotherapy in Elderly Patients with Locally Advanced Adenocarcinoma of the Stomach and the Esophagogastric Junction: A Retrospective Cohort Analysis of Toxicity and Efficacy at the National Center for Tumor Diseases, Heidelberg.

Haag GM, Byl A, Jäger D, Berger AK. Haag GM, et al. Oncology. 2017;92(5):291-298. doi: 10.1159/000458531. Epub 2017 Mar 2. Oncology. 2017. PMID: 28249280

5

The postoperative part of perioperative chemotherapy fails to provide a survival benefit in completely resected esophagogastric adenocarcinoma.

Sisic L, Blank S, Nienhüser H, Haag GM, Jäger D, Bruckner T, Ott K, Schmidt T, Ulrich A. Sisic L, et al. Among authors: haag gm. Surg Oncol. 2020 Jun;33:177-188. doi: 10.1016/j.suronc.2017.06.001. Epub 2017 Jun 29. Surg Oncol. 2020. PMID: 28684226

6

Postoperative follow-up programs improve survival in curatively resected gastric and junctional cancer patients: a propensity score matched analysis.

Sisic L, Strowitzki MJ, Blank S, Nienhueser H, Dorr S, Haag GM, Jäger D, Ott K, Büchler MW, Ulrich A, Schmidt T. Sisic L, et al. Among authors: haag gm. Gastric Cancer. 2018 May;21(3):552-568. doi: 10.1007/s10120-017-0751-4. Epub 2017 Jul 24. Gastric Cancer. 2018. PMID: 28741059

7

Randomized controlled trial of S-1 maintenance therapy in metastatic esophagogastric cancer - the multinational MATEO study.

Haag GM, Stocker G, Quidde J, Jaeger D, Lordick F. Haag GM, et al. BMC Cancer. 2017 Jul 31;17(1):509. doi: 10.1186/s12885-017-3497-9. BMC Cancer. 2017. PMID: 28760152 Free PMC article.

8

Neoadjuvant Therapy Improves Outcomes in Locally Advanced Signet-Ring-Cell Containing Esophagogastric Adenocarcinomas.

Heger U, Sisic L, Nienhüser H, Blank S, Hinz U, Haag GM, Ott K, Ulrich A, Büchler MW, Schmidt T. Heger U, et al. Among authors: haag gm. Ann Surg Oncol. 2018 Aug;25(8):2418-2427. doi: 10.1245/s10434-018-6541-3. Epub 2018 May 31. Ann Surg Oncol. 2018. PMID: 29855828

9

Prognostic differences in 8th edition TNM staging of esophagogastric adenocarcinoma after neoadjuvant treatment.

Sisic L, Blank S, Nienhüser H, Dorr S, Haag GM, Jäger D, Bruckner T, Müller-Stich BP, Ott K, Büchler MW, Ulrich A, Schmidt T. Sisic L, et al. Among authors: haag gm. Eur J Surg Oncol. 2018 Oct;44(10):1646-1656. doi: 10.1016/j.ejso.2018.06.030. Epub 2018 Jul 7. Eur J Surg Oncol. 2018. PMID: 30082176

10

Prognostic significance of microsatellite-instability in gastric and gastroesophageal junction cancer patients undergoing neoadjuvant chemotherapy.

Haag GM, Czink E, Ahadova A, Schmidt T, Sisic L, Blank S, Heger U, Apostolidis L, Berger AK, Springfeld C, Lasitschka F, Jäger D, von Knebel Doeberitz M, Kloor M. Haag GM, et al. Int J Cancer. 2019 Apr 1;144(7):1697-1703. doi: 10.1002/ijc.32030. Epub 2019 Jan 4. Int J Cancer. 2019. PMID: 30499151 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

60 results

Search Page